Athira pharma appoints javier san martin, m.d., as chief medical officer

Bothell, wash., april 15, 2024 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the appointment of javier san martin, m.d.
ATHA Ratings Summary
ATHA Quant Ranking